Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05383326 · ClinicalTrials.gov registry record
Longitudinal Analysis of the Vaginal Microbiome
A clinical trial, sponsored by Viome.
- Completed
- Registry status
- 29
- Enrollment target
NCT05383326 is a clinical trial that has completed, run by Viome. The registered enrollment target is 29 participants.
The verdict
NCT05383326 has completed, sponsored by Viome.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This is a longitudinal, observational study with the goal of understanding vaginal microbiome changes both within a single day and across a menstrual cycle. The study will be composed of at least 10 women that have regular menstrual cycles and are 18 years of age or older. This study is direct to participant and will NOT utilize clinical sites.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-07-07 |
| Est. Completion | 2023-08-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05383326
The ClinicalTrials.gov registry entry for NCT05383326 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Viome, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05383326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05383326 about?
NCT05383326 is a clinical study titled "Longitudinal Analysis of the Vaginal Microbiome". This is a longitudinal, observational study with the goal of understanding vaginal microbiome changes both within a single day and across a menstrual cycle. The study will be composed of at least 10 women that have regular menstrual cycles and are 18 years of age or older. This study is direct to pa...
What is the current status of trial NCT05383326?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2022-07-07. Estimated completion is 2023-08-20.
Who is sponsoring clinical trial NCT05383326?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.